Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH

NCT01721707 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped withdrawn by industry

Conditions

Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Latanoprost+Brinzolamide combination
DRUG: Latanoprost

Sponsor

Adapt Produtos Oftalmológicos Ltda.